{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T06:11:59Z","timestamp":1778825519450,"version":"3.51.4"},"reference-count":305,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T00:00:00Z","timestamp":1778803200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:p>Non-small cell lung cancer (NSCLC) remains the leading cause of cancer-related mortality, and a substantial fraction of patients with resected early-stage disease experience recurrence despite curative-intent surgery. Current pathologic staging does not completely capture the biological heterogeneity that supports metastasis and drives relapse in node-negative patients. Development of robust prognostic and predictive biomarkers are needed to predict which early-stage patients are likely to progress and require additional treatment. Increasing evidence indicates that antitumor immunity is a major determinant of clinical outcome and therapeutic responsiveness. This is particularly relevant in the era of neoadjuvant, adjuvant, and perioperative immune checkpoint blockade where harnessing the potential antitumor properties of the immune system is essential. While most biomarker efforts have focused on the primary tumor alone, antitumor immune responses are orchestrated across multiple compartments, including tumor-surrounding lymph nodes, where antigen presentation, germinal center reactions including T and B cell priming and memory formation occur contributing to immunologic remodeling that can precede overt metastasis. Here, we review the cellular, transcriptional, and spatial architecture of the tumor\u2013immune microenvironment (TIME) and lymph node immune microenvironment (LIME) in human NSCLC, emphasizing how immune cell composition, cell state, clonal dynamics, and spatial organization influence progression, recurrence risk, and response to immunomodulatory therapies. This review highlights the current technical and translational advantages and limitations of multimodal single cell technologies and discuss potential directions for early-stage NSCLC staging and optimizing therapy timing through leveraging TIME\u2013LIME assessment utilizing multimodal technologies.<\/jats:p>","DOI":"10.3389\/fonc.2026.1803196","type":"journal-article","created":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T05:43:31Z","timestamp":1778823811000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["The evolving role of the immune microenvironment of tumor draining lymph nodes in the development of biomarkers of non-small cell lung cancer"],"prefix":"10.3389","volume":"16","author":[{"given":"Zhan Hao","family":"Xi","sequence":"first","affiliation":[{"name":"Department of Medicine, Section of Computational Biomedicine, Boston University Chobanian & Avedisian School of Medicine","place":["Boston, MA, United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin","family":"Zollinger","sequence":"additional","affiliation":[{"name":"Division of Thoracic Surgery, Inova Schar Cancer Institute","place":["Fairfax, VA, United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yusuke","family":"Koga","sequence":"additional","affiliation":[{"name":"Department of Medicine, Section of Computational Biomedicine, Boston University Chobanian & Avedisian School of Medicine","place":["Boston, MA, United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jason","family":"Weis","sequence":"additional","affiliation":[{"name":"Department of Medicine, Section of Computational Biomedicine, Boston University Chobanian & Avedisian School of Medicine","place":["Boston, MA, United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joshua D.","family":"Campbell","sequence":"additional","affiliation":[{"name":"Department of Medicine, Section of Computational Biomedicine, Boston University Chobanian & Avedisian School of Medicine","place":["Boston, MA, United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah A.","family":"Mazzilli","sequence":"additional","affiliation":[{"name":"Department of Medicine, Section of Computational Biomedicine, Boston University Chobanian & Avedisian School of Medicine","place":["Boston, MA, United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kei","family":"Suzuki","sequence":"additional","affiliation":[{"name":"Division of Thoracic Surgery, Inova Schar Cancer Institute","place":["Fairfax, VA, United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,5,15]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"e1S","DOI":"10.1378\/chest.12-2345","article-title":"Epidemiology of lung cancer","volume":"143","author":"Alberg","year":"2013","journal-title":"Chest"},{"key":"B2","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3322\/caac.21871","article-title":"Cancer statistics, 2025","volume":"75","author":"Siegel","year":"2025","journal-title":"CA A Cancer J Clin"},{"key":"B3","unstructured":"Cancer of the lung and bronchus - Cancer Stat Facts\n          \n          \n          2023"},{"key":"B4","volume-title":"Staging manual in thoracic oncology 3rd edition","author":"Asamura","year":"2024"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1097\/LBR.0000000000000545","article-title":"Preoperative staging by EBUS in cN0\/N1 lung cancer: Systematic review and meta-analysis","volume":"26","author":"Leong","year":"2019","journal-title":"J Bronchol Interventional Pulmonol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtcvs.2010.11.008","article-title":"Randomized trial of mediastinal lymph node sampling versus complete lymphadenectomy during pulmonary resection in the patient with N0 or N1 (less than hilar) non\u2013small cell carcinoma: Results of the American College of Surgery Oncology Group Z0030 Trial","volume":"141","author":"Darling","year":"2011","journal-title":"J Thorac Cardiovasc Surg"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2023.11.042","article-title":"Recurrence-free survival in patients with surgically resected non-small cell lung cancer","volume":"165","author":"Rajaram","year":"2024","journal-title":"Chest"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2024.05.026","article-title":"The proposed ninth edition TNM classification of lung cancer","volume":"166","author":"Detterbeck","year":"2024","journal-title":"Chest"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2019.04.016","article-title":"Prognostic impact of the number of metastatic lymph nodes on the eighth edition of the TNM classification of NSCLC","volume":"14","author":"Katsumata","year":"2019","journal-title":"J Thorac Oncol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"3272","DOI":"10.1038\/s41467-020-17046-2","article-title":"Tumor invasion in draining lymph nodes is associated with Treg accumulation in breast cancer patients","volume":"11","author":"N\u00fa\u00f1ez","year":"2020","journal-title":"Nat Commun"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.01613","article-title":"Circulating T cell subpopulations correlate with immune responses at the tumor site and clinical response to PD1 inhibition in non-small cell lung cancer","volume":"9","author":"Manjarrez-Ordu\u00f1o","year":"2018","journal-title":"Front Immunol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3390\/curroncol32050262","article-title":"The spatial proximity of CD8+ FoxP3+PD-1+ cells to tumor cells: A more accurate predictor of immunotherapy outcomes in advanced non-small-cell lung cancer","volume":"32","author":"Hu","year":"2025","journal-title":"Curr Oncol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1016\/j.cell.2017.04.014","article-title":"Innate immune landscape in early lung adenocarcinoma by paired single-cell analyses","volume":"169","author":"Lavin","year":"2017","journal-title":"Cell"},{"key":"B14","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.ajpath.2011.09.029","article-title":"Elastase\/LPS-exposed mice exhibit impaired innate immune responses to bacterial challenge","volume":"180","author":"Ganesan","year":"2012","journal-title":"Am J Pathol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.656745","article-title":"Innate lymphoid cells as regulators of epithelial integrity: Therapeutic implications for inflammatory bowel diseases","volume":"8","author":"Schulz-Kuhnt","year":"2021","journal-title":"Front Med"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1038\/s41573-022-00493-5","article-title":"Adaptive immune resistance at the tumour site: Mechanisms and therapeutic opportunities","volume":"21","author":"Kim","year":"2022","journal-title":"Nat Rev Drug Discov"},{"key":"B17","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/s41571-021-00564-3","article-title":"Tumour burden and efficacy of immune-checkpoint inhibitors","volume":"19","author":"Dall\u2019Olio","year":"2022","journal-title":"Nat Rev Clin Oncol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.3390\/cancers14071823","article-title":"Enhanced T-cell priming and improved anti-tumor immunity through lymphatic delivery of checkpoint blockade immunotherapy","volume":"14","author":"Mantilla-Rojas","year":"2022"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-020-02792-5","article-title":"Tumor-draining lymph nodes are survival niches that support T cell priming against lymphatic transported tumor antigen and effects of immune checkpoint blockade in TNBC","volume":"70","author":"O\u2019Melia","year":"2021","journal-title":"Cancer Immunol Immunother"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1038\/ni.1946","article-title":"B cell follicles and antigen encounters of the third kind","volume":"11","author":"Cyster","year":"2010","journal-title":"Nat Immunol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-023-00990-6","article-title":"Dendritic cell subsets in cancer immunity and tumor antigen sensing","volume":"20","author":"Del Prete","year":"2023","journal-title":"Cell Mol Immunol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.01643","article-title":"Current concepts of antigen cross-presentation","volume":"9","author":"Embgenbroich","year":"2018","journal-title":"Front Immunol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2021.06.006","article-title":"Lymph node fibroblastic reticular cells steer immune responses","volume":"42","author":"Li","year":"2021","journal-title":"Trends Immunol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"2026.01.12.25343268","DOI":"10.64898\/2026.01.12.25343268","article-title":"Multimodal single-cell and spatial profiling reveals altered T cell-mediated immunity and B-cell follicular architecture in non-metastatic lymph nodes of patients with aggressive non-small cell lung cancer","author":"Xi","year":"2026","journal-title":"medRxiv"},{"key":"B25","doi-asserted-by":"publisher","first-page":"5810","DOI":"10.1038\/s41467-023-41518-w","article-title":"The tumor microenvironment shows a hierarchy of cell-cell interactions dominated by fibroblasts","volume":"14","author":"Mayer","year":"2023","journal-title":"Nat Commun"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12123650","article-title":"TGF-\u03b2 mediated immune evasion in cancer\u2014Spotlight on cancer-associated fibroblasts","volume":"12","author":"Ghahremanifard","year":"2020","journal-title":"Cancers"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.3390\/biom10121666","article-title":"Transforming growth factor-\u03b2 signaling in fibrotic diseases and cancer-associated fibroblasts","volume":"10","author":"Shi","year":"2020","journal-title":"Biomolecules"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-018-0014-x","article-title":"Understanding the tumor immune microenvironment (TIME) for effective therapy","volume":"24","author":"Binnewies","year":"2018","journal-title":"Nat Med"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1038\/ni1332","article-title":"T cell\u2013 and B cell\u2013independent adaptive immunity mediated by natural killer cells","volume":"7","author":"O\u2019Leary","year":"2006","journal-title":"Nat Immunol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2020-001813","article-title":"Tumor-infiltrating plasmacytoid dendritic cells are associated with survival in human colon cancer","volume":"9","author":"Kie\u00dfler","year":"2021","journal-title":"J Immunother Cancer"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.749190","article-title":"The role of plasmacytoid dendritic cells in cancers","volume":"12","author":"Zhou","year":"2021","journal-title":"Front Immunol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1007\/s00018-017-2686-7","article-title":"CD4 and CD8 T lymphocyte interplay in controlling tumor growth","volume":"75","author":"Ostroumov","year":"2018","journal-title":"Cell Mol Life Sci"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-023-01510-4","article-title":"CD4+ T cell memory","volume":"24","author":"K\u00fcnzli","year":"2023","journal-title":"Nat Immunol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1016\/j.cell.2023.02.021","article-title":"Dynamic CD8+ T cell responses to cancer immunotherapy in human regional lymph nodes are disrupted in metastatic lymph nodes","volume":"186","author":"Rahim","year":"2023","journal-title":"Cell"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2020.07.014","article-title":"The more, the merrier: DC3s join the human dendritic cell family","volume":"53","author":"Villar","year":"2020","journal-title":"Immunity"},{"key":"B36","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/s41698-025-00831-x","article-title":"Stage-dependent spatial distribution and prognostic value of CD8+ tissue-resident memory T cells in NSCLC","volume":"9","author":"Yang","year":"2025","journal-title":"NPJ Precis Onc"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01014","article-title":"Beyond cDC1: Emerging roles of DC crosstalk in cancer immunity","volume":"10","author":"Noubade","year":"2019","journal-title":"Front Immunol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1038\/s43018-023-00521-2","article-title":"CD4+ T cells in cancer","volume":"4","author":"Speiser","year":"2023","journal-title":"Nat Cancer"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-023-06199-x","article-title":"CD4+ T cell-induced inflammatory cell death controls immune-evasive tumours","volume":"618","author":"Kruse","year":"2023","journal-title":"Nature"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-021-00574-3","article-title":"CD8+ T cell differentiation and dysfunction in cancer","volume":"22","author":"Philip","year":"2022","journal-title":"Nat Rev Immunol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1126\/science.aaa6204","article-title":"T cell exclusion, immune privilege, and the tumor microenvironment","volume":"348","author":"Joyce","year":"2015","journal-title":"Science"},{"key":"B42","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1016\/j.immuni.2018.03.023","article-title":"The immune landscape of cancer","volume":"48","author":"Thorsson","year":"2018","journal-title":"Immunity"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1111\/imm.13067","article-title":"Intratumoral regulatory T cells: Markers, subsets and their impact on anti\u2010tumor immunity","volume":"157","author":"Yano","year":"2019","journal-title":"Immunology"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-18-4085","article-title":"The immune subtypes and landscape of squamous cell carcinoma","volume":"25","author":"Li","year":"2019","journal-title":"Clin Cancer Res"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.881427","article-title":"Emerging concepts regarding pro- and anti tumor properties of B cells in tumor immunity","volume":"13","author":"Qin","year":"2022","journal-title":"Front Immunol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"89","DOI":"10.36401\/JIPO-23-4","article-title":"T cell immunoglobulin and mucin domain containing protein 3 (TIM-3) inhibitors in oncology clinical trials: A review","volume":"7","author":"Duong","year":"2024","journal-title":"J Immunother Precis Oncol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-023-06816-9","article-title":"Dictionary of immune responses to cytokines at single-cell resolution","volume":"625","author":"Cui","year":"2024","journal-title":"Nature"},{"key":"B48","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/j.immuni.2023.01.010","article-title":"Tissue-specific abundance of interferon-gamma drives regulatory T cells to restrain DC1-mediated priming of cytotoxic T cells against lung cancer","volume":"56","author":"Zagorulya","year":"2023","journal-title":"Immunity"},{"key":"B49","doi-asserted-by":"publisher","first-page":"eadf4726","DOI":"10.1126\/sciimmunol.adf4726","article-title":"Architects of immunity: How dendritic cells shape CD8+ T cell fate in cancer","volume":"10","author":"Bhandarkar","year":"2025","journal-title":"Sci Immunol"},{"key":"B50","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1016\/j.ccell.2019.05.005","article-title":"Targeting tumors with IL-10 prevents dendritic cell-mediated CD8+ T cell apoptosis","volume":"35","author":"Qiao","year":"2019","journal-title":"Cancer Cell"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-021-00940-2","article-title":"Metabolic reprogramming of terminally exhausted CD8+ T cells by IL-10 enhances anti-tumor immunity","volume":"22","author":"Guo","year":"2021","journal-title":"Nat Immunol"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-024-01133-1","article-title":"CD4+ T cells produce IFN-I to license cDC1s for induction of cytotoxic T-cell activity in human tumors","volume":"21","author":"Lei","year":"2024","journal-title":"Cell Mol Immunol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1038\/nri3845","article-title":"Type I interferons in anticancer immunity","volume":"15","author":"Zitvogel","year":"2015","journal-title":"Nat Rev Immunol"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1038\/nrc3239","article-title":"The blockade of immune checkpoints in cancer immunotherapy","volume":"12","author":"Pardoll","year":"2012"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2018.07.017","article-title":"Innate lymphoid cells: 10 years on","volume":"174","author":"Vivier","year":"2018","journal-title":"Cell"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a032102","article-title":"Do memory CD4 T cells keep their cell-type programming: Plasticity versus fate commitment?: Complexities of interpretation due to the heterogeneity of memory CD4 T cells, including T follicular helper cells","volume":"10","author":"Crotty","year":"2018","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-020-0282-9","article-title":"Plasticity of innate lymphoid cell subsets","volume":"20","author":"Bal","year":"2020","journal-title":"Nat Rev Immunol"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1038\/nri.2015.18","article-title":"Harnessing the plasticity of CD4+ T cells to treat immune-mediated disease","volume":"16","author":"DuPage","year":"2016","journal-title":"Nat Rev Immunol"},{"key":"B59","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/nature14189","article-title":"The biology of innate lymphoid cells","volume":"517","author":"Artis","year":"2015","journal-title":"Nature"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.838484","article-title":"Cytotoxic efficiency of human CD8+ T cell memory subtypes","volume":"13","author":"Kn\u00f6rck","year":"2022","journal-title":"Front Immunol"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-020-01048-4","article-title":"Cytotoxic CD8+ T cells in cancer and cancer immunotherapy","volume":"124","author":"Raskov","year":"2021","journal-title":"Br J Cancer"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-019-0221-9","article-title":"Defining \u2018T cell exhaustion.\u2019","volume":"19","author":"Blank","year":"2019","journal-title":"Nat Rev Immunol"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.715234","article-title":"CD8+ T cell exhaustion in cancer","volume":"12","author":"Dolina","year":"2021","journal-title":"Front Immunol"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-041015-055318","article-title":"CD8 T cell exhaustion during chronic viral infection and cancer","volume":"37","author":"McLane","year":"2019","journal-title":"Annu Rev Immunol"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2018.01.022","article-title":"Spatial interaction of tumor cells and regulatory T cells correlates with survival in non-small cell lung cancer","volume":"117","author":"Barua","year":"2018","journal-title":"Lung Cancer"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1293618","article-title":"Location matters: spatial dynamics of tumor-infiltrating T cell subsets is prognostic in colon cancer","volume":"15","author":"Zhu","year":"2024","journal-title":"Front Immunol"},{"key":"B67","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/s41523-025-00728-9","article-title":"Spatial proximity of CD8+ T cells to tumor cells predicts neoadjuvant therapy efficacy in breast cancer","volume":"11","author":"Liang","year":"2025","journal-title":"NPJ Breast Cancer"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1016\/j.labinv.2023.100259","article-title":"Spatial proximity and relative distribution of tumor-infiltrating lymphocytes and macrophages predict survival in melanoma","volume":"103","author":"De Logu","year":"2023","journal-title":"Lab Invest"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.674375","article-title":"Therapeutic induction of tertiary lymphoid structures in cancer through stromal remodeling","volume":"12","author":"Johansson-Percival","year":"2021","journal-title":"Front Immunol"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.698604","article-title":"Tumor-associated tertiary lymphoid structures: From basic and clinical knowledge to therapeutic manipulation","volume":"12","author":"Domblides","year":"2021","journal-title":"Front Immunol"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a026781","article-title":"Tumor microenvironment and differential responses to therapy","volume":"7","author":"Hirata","year":"2017","journal-title":"Cold Spring Harb Perspect Med"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.5698","article-title":"Role of tumor microenvironment in cancer progression and therapeutic strategy","volume":"12","author":"Wang","year":"2023","journal-title":"Cancer Med"},{"key":"B73","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1016\/j.cell.2017.09.028","article-title":"Tumor and microenvironment evolution during immunotherapy with nivolumab","volume":"171","author":"Riaz","year":"2017","journal-title":"Cell"},{"key":"B74","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.ccell.2023.02.016","article-title":"The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth","volume":"41","author":"De Visser","year":"2023","journal-title":"Cancer Cell"},{"key":"B75","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s40164-022-00277-y","article-title":"Heterogeneity of the tumor immune microenvironment and its clinical relevance","volume":"11","author":"Jia","year":"2022","journal-title":"Exp Hematol Oncol"},{"key":"B76","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/s41419-017-0061-0","article-title":"Defining the role of the tumor vasculature in antitumor immunity and immunotherapy","volume":"9","author":"Schaaf","year":"2018","journal-title":"Cell Death Dis"},{"key":"B77","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1038\/s41698-024-00639-1","article-title":"Prognostic patterns in invasion lymph nodes of lung adenocarcinoma reveal distinct tumor microenvironments","volume":"8","author":"Lao","year":"2024","journal-title":"NPJ Precis Onc"},{"key":"B78","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.annonc.2021.09.021","article-title":"Distinct tumor-infiltrating lymphocyte landscapes are associated with clinical outcomes in localized non-small-cell lung cancer","volume":"33","author":"Federico","year":"2022","journal-title":"Ann Oncol"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12092607","article-title":"The origin and immune recognition of tumor-specific antigens","volume":"12","author":"Apavaloaei","year":"2020","journal-title":"Cancers"},{"key":"B80","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/s41568-021-00339-z","article-title":"Antigen presentation in cancer: insights into tumour immunogenicity and immune evasion","volume":"21","author":"Jhunjhunwala","year":"2021","journal-title":"Nat Rev Cancer"},{"key":"B81","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/s41577-025-01208-8","article-title":"Defects in antigen processing and presentation: mechanisms, immune evasion and implications for cancer vaccine development","volume":"26","author":"Huber","year":"2026","journal-title":"Nat Rev Immunol"},{"key":"B82","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.trecan.2023.09.006","article-title":"The tumor-draining lymph node as a reservoir for systemic immune surveillance","volume":"10","author":"Delclaux","year":"2024","journal-title":"Trends Cancer"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1038\/ni1134","article-title":"Distinct T cell dynamics in lymph nodes during the induction of tolerance and immunity","volume":"5","author":"Hugues","year":"2004","journal-title":"Nat Immunol"},{"key":"B84","doi-asserted-by":"publisher","first-page":"1924","DOI":"10.1016\/j.cell.2022.04.019","article-title":"Lymph node colonization induces tumor-immune tolerance to promote distant metastasis","volume":"185","author":"Reticker-Flynn","year":"2022","journal-title":"Cell"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2017.11.132","article-title":"Stromal PD-L1\u2013positive regulatory T cells and PD-1\u2013positive CD8-positive T cells define the response of different subsets of non\u2013small cell lung cancer to PD-1\/PD-L1 blockade immunotherapy","volume":"13","author":"Wu","year":"2018","journal-title":"J Thorac Oncol"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.abd5778","article-title":"Contribution of resident and circulating precursors to tumor-infiltrating CD8+ T cell populations in lung cancer","volume":"6","author":"Gueguen","year":"2021","journal-title":"Sci Immunol"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-21-1658","article-title":"The single-cell immunogenomic landscape of B and plasma cells in early-stage lung adenocarcinoma","volume":"12","author":"Hao","year":"2022","journal-title":"Cancer Discov"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1562797","article-title":"Immune microenvironment of tumor-draining lymph nodes: insights for immunotherapy","volume":"16","author":"Wei","year":"2025","journal-title":"Front Immunol"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1126\/science.abf9419","article-title":"Tertiary lymphoid structures in cancer","volume":"375","author":"Schumacher","year":"2022","journal-title":"Science"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2015.00067","article-title":"Tertiary lymphoid structure-associated B cells are key players in anti-tumor immunity","volume":"6","author":"Germain","year":"2015","journal-title":"Front Immunol"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-024-00728-0","article-title":"Tertiary lymphoid structures in anticancer immunity","volume":"24","author":"Teillaud","year":"2024","journal-title":"Nat Rev Cancer"},{"key":"B92","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1038\/s44276-025-00146-1","article-title":"B cells and tertiary lymphoid structures in cancer therapy response","volume":"3","author":"Hegoburu","year":"2025","journal-title":"BJC Rep"},{"key":"B93","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1038\/s43018-021-00232-6","article-title":"Mature tertiary lymphoid structures predict immune checkpoint inhibitor efficacy in solid tumors independently of PD-L1 expression","volume":"2","author":"Vanhersecke","year":"2021","journal-title":"Nat Cancer"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2022-005539","article-title":"Intratumoral tertiary lymphoid structure (TLS) maturation is influenced by draining lymph nodes of lung cancer","volume":"11","author":"He","year":"2023","journal-title":"J Immunother Cancer"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-022-03353-8","article-title":"Preventive effect of tertiary lymphoid structures on lymph node metastasis of lung adenocarcinoma","volume":"72","author":"Wakasu","year":"2023","journal-title":"Cancer Immunol Immunother"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.abg3551","article-title":"Tumor-draining lymph nodes: At the crossroads of metastasis and immunity","volume":"6","author":"du Bois","year":"2021","journal-title":"Sci Immunol"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1038\/nri1919","article-title":"Tumour\u2013induced immune modulation of sentinel lymph nodes","volume":"6","author":"Cochran","year":"2006","journal-title":"Nat Rev Immunol"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1038\/s41596-025-01200-5","article-title":"Spontaneous and experimental models of lymph node metastasis","volume":"20","author":"Breuer","year":"2025","journal-title":"Nat Protoc"},{"key":"B99","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1002\/1878-0261.13047","article-title":"Breast cancer metastasis: immune profiling of lymph nodes reveals exhaustion of effector T cells and immunosuppression","volume":"16","author":"Rye","year":"2022","journal-title":"Mol Oncol"},{"key":"B100","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1038\/s41392-023-01576-4","article-title":"Lymph node metastasis in cancer progression: molecular mechanisms, clinical significance and therapeutic interventions","volume":"8","author":"Ji","year":"2023","journal-title":"Sig Transduct Target Ther"},{"key":"B101","doi-asserted-by":"publisher","first-page":"24","DOI":"10.21037\/tlcr-21-751","article-title":"A prediction model integrated genomic alterations and immune signatures of tumor immune microenvironment for early recurrence of stage I NSCLC after curative resection","volume":"11","author":"Hu","year":"2022","journal-title":"Transl Lung Cancer Res"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1038\/ni.2965","article-title":"B cell homeostasis and follicle confines are governed by fibroblastic reticular cells","volume":"15","author":"Cremasco","year":"2014","journal-title":"Nat Immunol"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.952220","article-title":"Spatial biology analysis reveals B cell follicles in secondary lymphoid structures may regulate anti-tumor responses at initial melanoma diagnosis","volume":"13","author":"Therien","year":"2022","journal-title":"Front Immunol"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2018.09.010","article-title":"The impact of radiation therapy on lymphocyte count and survival in metastatic cancer patients receiving PD-1 immune checkpoint inhibitors","volume":"103","author":"Pike","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2020-000867","article-title":"Tumor-draining lymph node is important for a robust abscopal effect stimulated by radiotherapy","volume":"8","author":"Buchwald","year":"2020","journal-title":"J Immunother Cancer"},{"key":"B106","doi-asserted-by":"publisher","first-page":"5500","DOI":"10.1038\/s41467-024-49873-y","article-title":"Delayed tumor-draining lymph node irradiation preserves the efficacy of combined radiotherapy and immune checkpoint blockade in models of metastatic disease","volume":"15","author":"Telarovic","year":"2024","journal-title":"Nat Commun"},{"key":"B107","doi-asserted-by":"publisher","first-page":"7015","DOI":"10.1038\/s41467-022-34676-w","article-title":"Elective nodal irradiation mitigates local and systemic immunity generated by combination radiation and immunotherapy in head and neck tumors","volume":"13","author":"Darragh","year":"2022","journal-title":"Nat Commun"},{"key":"B108","article-title":"CD8+ T cells infiltrated within cancer cell nests as a prognostic factor in human colorectal cancer","volume":"58","author":"Naito","year":"1998","journal-title":"Cancer Res"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1126\/science.1129139","article-title":"Type, density, and location of immune cells within human colorectal tumors predict clinical outcome","volume":"313","author":"Galon","year":"2006","journal-title":"Science"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0611618104","article-title":"CD8 tumor-infiltrating lymphocytes are predictive of survival in muscle-invasive urothelial carcinoma","volume":"104","author":"Sharma","year":"2007","journal-title":"Proc Natl Acad Sci"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6602934","article-title":"Concurrent infiltration by CD8+ T cells and CD4+ T cells is a favourable prognostic factor in non-small-cell lung carcinoma","volume":"94","author":"Hiraoka","year":"2006","journal-title":"Br J Cancer"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-08-0133","article-title":"Prognostic effect of epithelial and stromal lymphocyte infiltration in non-small cell lung cancer","volume":"14","author":"Al-Shibli","year":"2008","journal-title":"Clin Cancer Res"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.23712","article-title":"Predominant infiltration of macrophages and CD8(+) T cells in cancer nests is a significant predictor of survival in stage IV nonsmall cell lung cancer","volume":"113","author":"Kawai","year":"2008","journal-title":"Cancer"},{"key":"B114","article-title":"Infiltration of CD8+ FOXP3+ T cells, CD8+ T cells, and FOXP3+ T cells in non-small cell lung cancer microenvironment","volume":"13","author":"Hao","year":"2020","journal-title":"Int J Clin Exp Pathol"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1084887","article-title":"Towards a consensus definition of immune exclusion in cancer","volume":"14","author":"Tiwari","year":"2023","journal-title":"Front Immunol"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2023.09.011","article-title":"The cancer-immunity cycle: Indication, genotype, and immunotype","volume":"56","author":"Mellman","year":"2023","journal-title":"Immunity"},{"key":"B117","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.immuni.2019.12.011","article-title":"Top 10 challenges in cancer immunotherapy","volume":"52","author":"Hegde","year":"2020","journal-title":"Immunity"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00563","article-title":"Immunological approaches towards cancer and inflammation: A cross talk","volume":"9","author":"Qu","year":"2018","journal-title":"Front Immunol"},{"key":"B119","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.immuni.2019.06.025","article-title":"Inflammation and cancer: Triggers, mechanisms, and consequences","volume":"51","author":"Greten","year":"2019","journal-title":"Immunity"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.633534","article-title":"Case report: Transformation from cold to hot tumor in a case of NSCLC neoadjuvant immunochemotherapy pseudoprogression","volume":"12","author":"Jia","year":"2021","journal-title":"Front Immunol"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1002\/cac2.12539","article-title":"Immunologic tumor microenvironment modulators for turning cold tumors hot","volume":"44","author":"Khosravi","year":"2024","journal-title":"Cancer Commun"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1016\/j.trecan.2025.11.011","article-title":"Small-cell lung cancer: Anatomy of an immune-cold tumor","volume":"12","author":"Millrine","year":"2025","journal-title":"Trends Cancer"},{"key":"B123","doi-asserted-by":"publisher","first-page":"4186","DOI":"10.1038\/s41467-019-12160-2","article-title":"B cells sustain inflammation and predict response to immune checkpoint blockade in human melanoma","volume":"10","author":"Griss","year":"2019","journal-title":"Nat Commun"},{"key":"B124","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1038\/s41467-017-00608-2","article-title":"Predictors of responses to immune checkpoint blockade in advanced melanoma","volume":"8","author":"Jacquelot","year":"2017","journal-title":"Nat Commun"},{"key":"B125","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/bjc.2017.136","article-title":"Hallmarks of response to immune checkpoint blockade","volume":"117","author":"Cogdill","year":"2017","journal-title":"Br J Cancer"},{"key":"B126","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1016\/j.immuni.2020.10.020","article-title":"Antagonistic inflammatory phenotypes dictate tumor fate and response to immune checkpoint blockade","volume":"53","author":"Bonavita","year":"2020","journal-title":"Immunity"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-019-0235-4","article-title":"CD8+ T cell states in human cancer: Insights from single-cell analysis","volume":"20","author":"van der Leun","year":"2020","journal-title":"Nat Rev Cancer"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00784","article-title":"The tumor microenvironment in the response to immune checkpoint blockade therapies","volume":"11","author":"Petitprez","year":"2020","journal-title":"Front Immunol"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-23-0873","article-title":"Machine learning links T-cell function and spatial localization to neoadjuvant immunotherapy and clinical outcome in pancreatic cancer","volume":"12","author":"Blise","year":"2024","journal-title":"Cancer Immunol Res"},{"key":"B130","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1016\/j.cell.2020.07.005","article-title":"Coordinated cellular neighborhoods orchestrate antitumoral immunity at the colorectal cancer invasive front","volume":"182","author":"Sch\u00fcrch","year":"2020","journal-title":"Cell"},{"key":"B131","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1016\/j.cell.2018.08.039","article-title":"A structured tumor-immune microenvironment in triple negative breast cancer revealed by multiplexed ion beam imaging","volume":"174","author":"Keren","year":"2018","journal-title":"Cell"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-019-0312-6","article-title":"Subsets of exhausted CD8+ T cells differentially mediate tumor control and respond to checkpoint blockade","volume":"20","author":"Miller","year":"2019","journal-title":"Nat Immunol"},{"key":"B133","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1016\/j.cell.2018.10.038","article-title":"Defining T cell states associated with response to checkpoint immunotherapy in melanoma","volume":"175","author":"Sade-Feldman","year":"2018","journal-title":"Cell"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.21037\/tlcr-24-284","article-title":"Stem-like exhausted CD8 T cells in pleural effusions predict improved survival in non-small cell lung cancer (NSCLC) and mesothelioma","volume":"13","author":"Ye","year":"2024","journal-title":"Trans Lung Cancer Res"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2024-009126","article-title":"Spatial colocalization and combined survival benefit of natural killer and CD8 T cells despite profound MHC class I loss in non-small cell lung cancer","volume":"12","author":"Wessel","year":"2024","journal-title":"J Immunother Cancer"},{"key":"B136","doi-asserted-by":"publisher","first-page":"2364","DOI":"10.1038\/s41467-023-37905-y","article-title":"Immune cellular patterns of distribution affect outcomes of patients with non-small cell lung cancer","volume":"14","author":"Parra","year":"2023","journal-title":"Nat Commun"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abd9738","article-title":"Decoding the multicellular ecosystem of lung adenocarcinoma manifested as pulmonary subsolid nodules by single-cell RNA sequencing","volume":"7","author":"Xing","year":"2021","journal-title":"Sci Adv"},{"key":"B138","doi-asserted-by":"publisher","first-page":"14111","DOI":"10.1038\/s41598-022-18340-3","article-title":"Heterogeneity of circulating CD4+CD8+ double-positive T cells characterized by scRNA-seq analysis and trajectory inference","volume":"12","author":"Choi","year":"2022","journal-title":"Sci Rep"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.add1016","article-title":"Multiomics and spatial mapping characterizes human CD8+ T cell states in cancer","volume":"15","author":"Naulaerts","year":"2023","journal-title":"Sci Transl Med"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1661545","article-title":"Infiltration characteristics and regulatory mechanisms of CD8+ T lymphocytes in solid tumors: Spatial distribution, biological functions, and interactions with the immune microenvironment","volume":"16","author":"Ouyang","year":"2025","journal-title":"Front Immunol"},{"key":"B141","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1186\/s12967-024-05606-9","article-title":"Re-analysis of single cell and spatial transcriptomics data reveals B cell landscape in gastric cancer microenvironment and its potential crosstalk with tumor cells for clinical prognosis","volume":"22","author":"Cai","year":"2024","journal-title":"J Transl Med"},{"key":"B142","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.02692","article-title":"Defining memory CD8 T cell","volume":"9","author":"Martin","year":"2018","journal-title":"Front Immunol"},{"key":"B143","doi-asserted-by":"publisher","first-page":"2477","DOI":"10.1016\/j.molcel.2021.03.045","article-title":"A unified atlas of CD8 T cell dysfunctional states in cancer and infection","volume":"81","author":"Pritykin","year":"2021","journal-title":"Mol Cell"},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.adg3868","article-title":"Cellular and molecular waypoints along the path of T cell exhaustion","volume":"8","author":"Lan","year":"2023","journal-title":"Sci Immunol"},{"key":"B145","doi-asserted-by":"publisher","first-page":"7543","DOI":"10.1038\/s41467-022-35281-7","article-title":"Identification of human progenitors of exhausted CD8+ T cells associated with elevated IFN-\u03b3 response in early phase of viral infection","volume":"13","author":"Cai","year":"2022","journal-title":"Nat Commun"},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-025-01221-x","article-title":"Regulators of CD8+ T cell exhaustion","volume":"26","author":"Sun","year":"2025","journal-title":"Nat Rev Immunol"},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-24-0991","article-title":"Presence of tertiary lymphoid structures and exhausted tissue-resident T cells determines clinical response to PD-1 blockade in renal cell carcinoma","volume":"15","author":"Hugaboom","year":"2025","journal-title":"Cancer Discov"},{"key":"B148","doi-asserted-by":"publisher","first-page":"9033","DOI":"10.1038\/s41467-024-53262-w","article-title":"Spatial dynamics of CD39+CD8+ exhausted T cell reveal tertiary lymphoid structures-mediated response to PD-1 blockade in esophageal cancer","volume":"15","author":"Tanoue","year":"2024","journal-title":"Nat Commun"},{"key":"B149","doi-asserted-by":"publisher","DOI":"10.1111\/imr.70088","article-title":"T peripheral helper cells in lymphoid aggregate and tertiary lymphoid structure formation","volume":"337","author":"Sowerby","year":"2026","journal-title":"Immunol Rev"},{"key":"B150","doi-asserted-by":"publisher","first-page":"4228","DOI":"10.1038\/s41467-025-59341-w","article-title":"Mature tertiary lymphoid structures evoke intra-tumoral T and B cell responses via progenitor exhausted CD4+ T cells in head and neck cancer","volume":"16","author":"Li","year":"2025","journal-title":"Nat Commun"},{"key":"B151","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-018-0045-3","article-title":"Global characterization of T cells in non-small-cell lung cancer by single-cell sequencing","volume":"24","author":"Guo","year":"2018","journal-title":"Nat Med"},{"key":"B152","doi-asserted-by":"publisher","DOI":"10.1038\/nm1551","article-title":"A brief history of TH17, the first major revision in the TH1\/TH2 hypothesis of T cell\u2013mediated tissue damage","volume":"13","author":"Steinman","year":"2007","journal-title":"Nat Med"},{"key":"B153","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1658848","article-title":"Rewiring immune suppression in NSCLC: Roles and plasticity of Tregs and Th17 cells","volume":"16","author":"Zhu","year":"2025","journal-title":"Front Immunol"},{"key":"B154","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00676","article-title":"Inducers, attractors and modulators of CD4+ Treg cells in non-small-cell lung cancer","volume":"11","author":"Xie","year":"2020","journal-title":"Front Immunol"},{"key":"B155","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.adg1487","article-title":"Lung tumor\u2013infiltrating Treg have divergent transcriptional profiles and function linked to checkpoint blockade response","volume":"8","author":"Dykema","year":"2023","journal-title":"Sci Immunol"},{"key":"B156","doi-asserted-by":"publisher","first-page":"3913","DOI":"10.1038\/s41467-021-24213-6","article-title":"Single-cell transcriptomic analysis reveals disparate effector differentiation pathways in human Treg compartment","volume":"12","author":"Luo","year":"2021","journal-title":"Nat Commun"},{"key":"B157","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1408710","article-title":"Interleukin-17 directly stimulates tumor infiltrating Tregs to prevent cancer development","volume":"15","author":"Theune","year":"2024","journal-title":"Front Immunol"},{"key":"B158","doi-asserted-by":"publisher","first-page":"3998","DOI":"10.1016\/j.cell.2021.05.027","article-title":"Expansion of tumor-associated Treg cells upon disruption of a CTLA-4-dependent feedback loop","volume":"184","author":"Marangoni","year":"2021","journal-title":"Cell"},{"key":"B159","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.23392","article-title":"CCL17 and CCL22 chemokines within tumor microenvironment are related to accumulation of Foxp3+ regulatory T cells in gastric cancer","volume":"122","author":"Mizukami","year":"2008","journal-title":"Int J Cancer"},{"key":"B160","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01942","article-title":"Regulatory T cells control the switch from in situ to invasive breast cancer","volume":"10","author":"Martinez","year":"2019","journal-title":"Front Immunol"},{"key":"B161","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2015.08.006","article-title":"Regulatory T cells in tumor-associated tertiary lymphoid structures suppress anti-tumor T cell responses","volume":"43","author":"Joshi","year":"2015","journal-title":"Immunity"},{"key":"B162","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1038\/s42003-022-04356-y","article-title":"Regulatory T cells infiltrate the tumor-induced tertiary lympho\u00efd structures and are associated with poor clinical outcome in NSCLC","volume":"5","author":"Devi-Marulkar","year":"2022","journal-title":"Commun Biol"},{"key":"B163","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-18-4275","article-title":"Tumor characteristics associated with benefit from pembrolizumab in advanced non\u2013small cell lung cancer","volume":"25","author":"Hu-Lieskovan","year":"2019","journal-title":"Clin Cancer Res"},{"key":"B164","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2021.01.013","article-title":"Surprising impact of stromal TIL\u2019s on immunotherapy efficacy in a real-world lung cancer study","volume":"153","author":"Hashemi","year":"2021","journal-title":"Lung Cancer"},{"key":"B165","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s12032-018-1080-0","article-title":"The role of tumor-infiltrating lymphocytes (TILs) as a predictive biomarker of response to anti-PD1 therapy in patients with metastatic non-small cell lung cancer or metastatic melanoma","volume":"35","author":"Uryvaev","year":"2018","journal-title":"Med Oncol"},{"key":"B166","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2012.45.2052","article-title":"Clinical impact of immune microenvironment in stage I lung adenocarcinoma: Tumor interleukin-12 receptor \u03b22 (IL-12R\u03b22), IL-7R, and stromal FoxP3\/CD3 ratio are independent predictors of recurrence","volume":"31","author":"Suzuki","year":"2013","journal-title":"JCO"},{"key":"B167","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1038\/s41591-018-0057-z","article-title":"A transcriptionally and functionally distinct PD-1+ CD8+ T cell pool with predictive potential in non-small-cell lung cancer treated with PD-1 blockade","volume":"24","author":"Thommen","year":"2018","journal-title":"Nat Med"},{"key":"B168","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.03101","article-title":"Immune cell composition in human non-small cell lung cancer","volume":"9","author":"Stankovic","year":"2019","journal-title":"Front Immunol"},{"key":"B169","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.764596","article-title":"The immune landscape of human primary lung tumors is Th2 skewed","volume":"12","author":"Frafjord","year":"2021","journal-title":"Front Immunol"},{"key":"B170","doi-asserted-by":"publisher","first-page":"3148","DOI":"10.1038\/s41467-022-30863-x","article-title":"Regulatory B cell repertoire defects predispose lung cancer patients to immune-related toxicity following checkpoint blockade","volume":"13","author":"Patel","year":"2022","journal-title":"Nat Commun"},{"key":"B171","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1198665","article-title":"Deep immune B and plasma cell repertoire in non-small cell lung cancer","volume":"14","author":"Patel","year":"2023","journal-title":"Front Immunol"},{"key":"B172","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1422206","article-title":"Exploring the impact of tertiary lymphoid structures maturity in NSCLC: insights from TLS scoring","volume":"15","author":"Berthe","year":"2024","journal-title":"Front Immunol"},{"key":"B173","article-title":"Prognostic markers in resectable non-small cell lung cancer: a multivariate analysis","volume":"44","author":"Pelletier","year":"2001","journal-title":"Can J Surg"},{"key":"B174","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.707143","article-title":"The prognosis and immune checkpoint blockade efficacy prediction of tumor-infiltrating immune cells in lung cancer","volume":"9","author":"Liu","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"B175","doi-asserted-by":"publisher","DOI":"10.1002\/path.5772","article-title":"Infiltration of NK and plasma cells is associated with a distinct immune subset in non\u2010small cell lung cancer","volume":"255","author":"Backman","year":"2021","journal-title":"J Pathol"},{"key":"B176","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-025-01021-1","article-title":"Tumour and microenvironment crosstalk in NSCLC progression and response to therapy","volume":"22","author":"Rahal","year":"2025","journal-title":"Nat Rev Clin Oncol"},{"key":"B177","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-023-00846-y","article-title":"Myeloid-derived suppressor cells in cancer and cancer therapy","volume":"21","author":"Lasser","year":"2024","journal-title":"Nat Rev Clin Oncol"},{"key":"B178","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.756722","article-title":"Single-cell RNA sequencing reveals the heterogeneity of tumor-associated macrophage in non-small cell lung cancer and differences between sexes","volume":"12","author":"Yang","year":"2021","journal-title":"Front Immunol"},{"key":"B179","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.799455","article-title":"Therapeutic implications of tumor microenvironment in lung cancer: Focus on immune checkpoint blockade","volume":"12","author":"Genova","year":"2022","journal-title":"Front Immunol"},{"key":"B180","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1016\/j.cell.2020.07.013","article-title":"TREM2 modulation remodels the tumor myeloid landscape enhancing anti-PD-1 immunotherapy","volume":"182","author":"Molgora","year":"2020","journal-title":"Cell"},{"key":"B181","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1038\/s41590-023-01475-4","article-title":"TREM2 macrophages drive NK cell paucity and dysfunction in lung cancer","volume":"24","author":"Park","year":"2023","journal-title":"Nat Immunol"},{"key":"B182","doi-asserted-by":"publisher","first-page":"111929","DOI":"10.1016\/j.celrep.2022.111929","article-title":"Spatial and single-cell transcriptomics decipher the cellular environment containing HLA-G+ cancer cells and SPP1+ macrophages in colorectal cancer","volume":"42","author":"Ozato","year":"2023","journal-title":"Cell Rep"},{"key":"B183","doi-asserted-by":"publisher","DOI":"10.1126\/science.ade2292","article-title":"CXCL9:SPP1 macrophage polarity identifies a network of cellular programs that control human cancers","volume":"381","author":"Bill","year":"2023","journal-title":"Science"},{"key":"B184","doi-asserted-by":"publisher","first-page":"4242","DOI":"10.1038\/s41467-025-59529-0","article-title":"SPP1 + macrophages cause exhaustion of tumor-specific T cells in liver metastases","volume":"16","author":"Trehan","year":"2025","journal-title":"Nat Commun"},{"key":"B185","doi-asserted-by":"publisher","first-page":"10637","DOI":"10.1038\/s41467-024-54671-7","article-title":"Spatially resolved gene expression profiling of tumor microenvironment reveals key steps of lung adenocarcinoma development","volume":"15","author":"Takano","year":"2024","journal-title":"Nat Commun"},{"key":"B186","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1038\/s41419-025-08376-4","article-title":"Th17-like cells and immunosuppressive macrophages infiltrate tertiary lymphoid structures with distinct maturation status in soft-tissue sarcoma","volume":"16","author":"Petroni","year":"2025","journal-title":"Cell Death Dis"},{"key":"B187","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-024-01998-y","article-title":"Multi-omic profiling highlights factors associated with resistance to immuno-chemotherapy in non-small-cell lung cancer","volume":"57","author":"Yan","year":"2025","journal-title":"Nat Genet"},{"key":"B188","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-024-00859-1","article-title":"Dendritic cells as orchestrators of anticancer immunity and immunotherapy","volume":"21","author":"Heras-Murillo","year":"2024","journal-title":"Nat Rev Clin Oncol"},{"key":"B189","doi-asserted-by":"publisher","DOI":"10.1038\/s43018-022-00338-5","article-title":"The interaction of CD4+ helper T cells with dendritic cells shapes the tumor microenvironment and immune checkpoint blockade response","volume":"3","author":"Cohen","year":"2022","journal-title":"Nat Cancer"},{"key":"B190","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/imm.12888","article-title":"Human dendritic cell subsets: an update","volume":"154","author":"Collin","year":"2018","journal-title":"Immunology"},{"key":"B191","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2134-y","article-title":"A conserved dendritic-cell regulatory program limits antitumour immunity","volume":"580","author":"Maier","year":"2020","journal-title":"Nature"},{"key":"B192","doi-asserted-by":"publisher","first-page":"8151","DOI":"10.1038\/s41467-025-62878-5","article-title":"Mature and migratory dendritic cells promote immune infiltration and response to anti-PD-1 checkpoint blockade in metastatic melanoma","volume":"16","author":"Yang","year":"2025","journal-title":"Nat Commun"},{"key":"B193","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.15.0284","article-title":"Long-term survival for patients with non-small-cell lung cancer with intratumoral lymphoid structures","volume":"26","author":"Dieu-Nosjean","year":"2008","journal-title":"J Clin Oncol"},{"key":"B194","doi-asserted-by":"publisher","DOI":"10.1038\/s41573-025-01210-8","article-title":"Targeting neutrophils for cancer therapy","volume":"24","author":"Kwak","year":"2025","journal-title":"Nat Rev Drug Discov"},{"key":"B195","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/s41590-024-02029-y","article-title":"The heterogeneity of neutrophils in cancer and its implication for therapeutic targeting","volume":"26","author":"Eruslanov","year":"2025","journal-title":"Nat Immunol"},{"key":"B196","doi-asserted-by":"publisher","DOI":"10.1038\/s41388-024-03004-5","article-title":"Neutrophils in cancer: dual roles through intercellular interactions","volume":"43","author":"Yu","year":"2024","journal-title":"Oncogene"},{"key":"B197","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1038\/s41423-024-01244-9","article-title":"Neutrophils in cancer: from biology to therapy","volume":"22","author":"Koenderman","year":"2025","journal-title":"Cell Mol Immunol"},{"key":"B198","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms14381","article-title":"Neutrophils dominate the immune cell composition in non-small cell lung cancer","volume":"8","author":"Kargl","year":"2017","journal-title":"Nat Commun"},{"key":"B199","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-020-00490-y","article-title":"Myeloid-derived suppressor cells in the era of increasing myeloid cell diversity","volume":"21","author":"Veglia","year":"2021","journal-title":"Nat Rev Immunol"},{"key":"B200","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01680","article-title":"The new era of cancer immunotherapy: targeting myeloid-derived suppressor cells to overcome immune evasion","volume":"11","author":"De Cicco","year":"2020","journal-title":"Front Immunol"},{"key":"B201","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-022-05672-3","article-title":"Single-cell spatial landscapes of the lung tumour immune microenvironment","volume":"614","author":"Sorin","year":"2023","journal-title":"Nature"},{"key":"B202","doi-asserted-by":"publisher","DOI":"10.1038\/s43018-025-00986-3","article-title":"The tumor microenvironment\u2019s role in the response to immune checkpoint blockade","volume":"6","author":"Aliazis","year":"2025","journal-title":"Nat Cancer"},{"key":"B203","doi-asserted-by":"publisher","DOI":"10.1097\/JTO.0000000000000617","article-title":"Prognostic impact of immune microenvironment in lung squamous cell carcinoma","volume":"10","author":"Kadota","year":"2015","journal-title":"J Thorac Oncol"},{"key":"B204","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2013.03.003","article-title":"Tumor-associated neutrophils and macrophages in non-small cell lung cancer: No immediate impact on patient outcome","volume":"81","author":"Carus","year":"2013","journal-title":"Lung Cancer"},{"key":"B205","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1093\/jnci\/djac178","article-title":"Fibroblast subsets in non-small cell lung cancer: Associations with survival, mutations, and immune features","volume":"115","author":"Pellinen","year":"2023","journal-title":"J Natl Cancer Inst"},{"key":"B206","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.ccell.2023.12.021","article-title":"Cancer-associated fibroblast phenotypes are associated with patient outcome in non-small cell lung cancer","volume":"42","author":"Cords","year":"2024","journal-title":"Cancer Cell"},{"key":"B207","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-022-04250-4","article-title":"Fibroblast activation protein in the tumor microenvironment predicts outcomes of PD-1 blockade therapy in advanced non-small cell lung cancer","volume":"149","author":"Zhao","year":"2023","journal-title":"J Cancer Res Clin Oncol"},{"key":"B208","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2016.00621","article-title":"The role of the tumor vasculature in the host immune response: Implications for therapeutic strategies targeting the tumor microenvironment","volume":"7","author":"Hendry","year":"2016","journal-title":"Front Immunol"},{"key":"B209","doi-asserted-by":"publisher","first-page":"2581","DOI":"10.1038\/s41467-026-70600-2","article-title":"Vascular invasion-associated gene expression is detectable in pre-surgical biopsies of stage I lung adenocarcinoma","volume":"17","author":"Steiner","year":"2026","journal-title":"Nat Commun"},{"key":"B210","doi-asserted-by":"publisher","DOI":"10.1111\/imr.12748","article-title":"Fibroblastic reticular cells at the nexus of innate and adaptive immune responses","volume":"289","author":"Perez-Shibayama","year":"2019","journal-title":"Immunol Rev"},{"key":"B211","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2023.02.002","article-title":"High endothelial venules in cancer: Regulation, function, and therapeutic implication","volume":"41","author":"Vella","year":"2023","journal-title":"Cancer Cell"},{"key":"B212","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1633235","article-title":"Lymphoid stroma in all its states","volume":"16","author":"Barbier","year":"2025","journal-title":"Front Immunol"},{"key":"B213","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1111\/imr.12981","article-title":"Differentiation and activation of fibroblastic reticular cells","volume":"302","author":"L\u00fctge","year":"2021","journal-title":"Immunol Rev"},{"key":"B214","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/j.cell.2024.10.042","article-title":"Fibroblastic reticular cells generate protective intratumoral T cell environments in lung cancer","volume":"188","author":"Onder","year":"2025","journal-title":"Cell"},{"key":"B215","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2023.106524","article-title":"Cancer cell-derived extracellular vesicles drive pre-metastatic niche formation of lymph node via IFNGR1\/JAK1\/STAT1-activated-PD-L1 expression on FRCs in head and neck cancer","volume":"145","author":"Han","year":"2023","journal-title":"Oral Oncol"},{"key":"B216","doi-asserted-by":"publisher","DOI":"10.1016\/j.trecan.2020.10.001","article-title":"The dual role of high endothelial venules in cancer progression versus immunity","volume":"7","author":"Milutinovic","year":"2021","journal-title":"Trends Cancer"},{"key":"B217","doi-asserted-by":"publisher","first-page":"7114","DOI":"10.1038\/ncomms8114","article-title":"Effector lymphocyte-induced lymph node-like vasculature enables naive T-cell entry into tumours and enhanced anti-tumour immunity","volume":"6","author":"Peske","year":"2015","journal-title":"Nat Commun"},{"key":"B218","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.ccell.2022.01.002","article-title":"Tumor-associated high endothelial venules mediate lymphocyte entry into tumors and predict response to PD-1 plus CTLA-4 combination immunotherapy","volume":"40","author":"Asrir","year":"2022","journal-title":"Cancer Cell"},{"key":"B219","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-19-2931","article-title":"Compartmental analysis of T-cell clonal dynamics as a function of pathologic response to neoadjuvant PD-1 blockade in resectable non\u2013small cell lung cancer","volume":"26","author":"Zhang","year":"2020","journal-title":"Clin Cancer Res"},{"key":"B220","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1038\/s41467-019-14273-0","article-title":"Comprehensive T cell repertoire characterization of non-small cell lung cancer","volume":"11","author":"Reuben","year":"2020","journal-title":"Nat Commun"},{"key":"B221","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-17-0256","article-title":"TCR repertoire intratumor heterogeneity in localized lung adenocarcinomas: An association with predicted neoantigen heterogeneity and postsurgical recurrence","volume":"7","author":"Reuben","year":"2017","journal-title":"Cancer Discov"},{"key":"B222","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.1099304","article-title":"Progress on neoadjuvant immunotherapy in resectable non-small cell lung cancer and potential biomarkers","volume":"12","author":"Wu","year":"2023","journal-title":"Front Oncol"},{"key":"B223","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-21-1200","article-title":"Pretreatment tissue TCR repertoire evenness is associated with complete pathologic response in patients with NSCLC receiving neoadjuvant chemoimmunotherapy","volume":"27","author":"Casarrubios","year":"2021","journal-title":"Clin Cancer Res"},{"key":"B224","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2311926","article-title":"Perioperative nivolumab in resectable lung cancer","volume":"390","author":"Cascone","year":"2024","journal-title":"N Engl J Med"},{"key":"B225","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1056\/NEJMoa2302983","article-title":"Perioperative pembrolizumab for early-stage non\u2013small-cell lung cancer","volume":"389","author":"Wakelee","year":"2023","journal-title":"N Engl J Med"},{"key":"B226","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2304875","article-title":"Perioperative durvalumab for resectable non\u2013small-cell lung cancer","volume":"389","author":"Heymach","year":"2023","journal-title":"N Engl J Med"},{"key":"B227","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2202170","article-title":"Neoadjuvant nivolumab plus chemotherapy in resectable lung cancer","volume":"386","author":"Forde","year":"2022","journal-title":"N Engl J Med"},{"key":"B228","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(22)00518-6","article-title":"Pembrolizumab versus placebo as adjuvant therapy for completely resected stage IB\u2013IIIA non-small-cell lung cancer (PEARLS\/KEYNOTE-091): an interim analysis of a randomised, triple-blind, phase 3 trial","volume":"23","author":"O\u2019Brien","year":"2022","journal-title":"Lancet Oncol"},{"key":"B229","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2025.17953","article-title":"Clinical outcomes of perioperative immunotherapy in resectable non\u2013small cell lung cancer","volume":"8","author":"Desai","year":"2025","journal-title":"JAMA Netw Open"},{"key":"B230","doi-asserted-by":"publisher","first-page":"CD015819","DOI":"10.1002\/14651858.CD015819","article-title":"Perioperative immunotherapy strategies for resectable non-small cell lung cancer","volume":"2025","author":"Marchal","year":"2025","journal-title":"Cochrane Database Systematic Rev"},{"key":"B231","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2016.10.007","article-title":"Checkpoint inhibitors in metastatic EGFR- mutated non\u2013small cell lung cancer\u2014A meta-analysis","volume":"12","author":"Lee","year":"2017","journal-title":"J Thorac Oncol"},{"key":"B232","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-15-3101","article-title":"EGFR mutations and ALK rearrangements are associated with low response rates to PD-1 pathway blockade in non\u2013small cell lung cancer: A retrospective analysis","volume":"22","author":"Gainor","year":"2016","journal-title":"Clin Cancer Res"},{"key":"B233","doi-asserted-by":"publisher","DOI":"10.1111\/crj.13761","article-title":"Clinical outcomes associated with neoadjuvant therapy for the treatment of resectable non\u2010small cell lung cancer in real\u2010world practice","volume":"18","author":"Huang","year":"2024","journal-title":"Clin Respir J"},{"key":"B234","doi-asserted-by":"publisher","DOI":"10.3389\/fsurg.2024.1500593","article-title":"Prognosis prediction using significant pathological response following neoadjuvant immunotherapy in resectable non-small-cell lung tumors: a meta-analysis","volume":"11","author":"Nie","year":"2024","journal-title":"Front Surg"},{"key":"B235","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.684070","article-title":"Surgical outcomes after neoadjuvant chemoimmunotherapy for resectable non-small cell lung cancer","volume":"11","author":"Hu","year":"2021","journal-title":"Front Oncol"},{"key":"B236","doi-asserted-by":"publisher","first-page":"26200","DOI":"10.1038\/s41598-024-78159-y","article-title":"The role of PD-L1 in patients with non-small cell lung cancer receiving neoadjuvant immune checkpoint inhibitor plus chemotherapy: a meta-analysis","volume":"14","author":"Mo","year":"2024","journal-title":"Sci Rep"},{"key":"B237","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(24)00498-4","article-title":"Perioperative chemotherapy and nivolumab in non-small-cell lung cancer (NADIM): 5-year clinical outcomes from a multicentre, single-arm, phase 2 trial","volume":"25","author":"Provencio","year":"2024","journal-title":"Lancet Oncol"},{"key":"B238","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2025.108588","article-title":"Neoadjuvant immunotherapy in early-stage NSCLC: navigating biomarker dilemmas and special population challenges","volume":"204","author":"Chen","year":"2025","journal-title":"Lung Cancer"},{"key":"B239","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1716078","article-title":"Neoadjuvant PD-1 blockade in resectable lung cancer","volume":"378","author":"Forde","year":"2018","journal-title":"N Engl J Med"},{"key":"B240","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-020-01224-2","article-title":"Neoadjuvant nivolumab or nivolumab plus ipilimumab in operable non-small cell lung cancer: the phase 2 randomized NEOSTAR trial","volume":"27","author":"Cascone","year":"2021","journal-title":"Nat Med"},{"key":"B241","doi-asserted-by":"publisher","DOI":"10.1016\/j.athoracsur.2008.10.067","article-title":"Clinical significance of tumor-infiltrating lymphocytes in lung neoplasms","volume":"87","author":"Ruffini","year":"2009","journal-title":"Ann Thorac Surg"},{"key":"B242","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)02333-3","article-title":"Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer (JCOG0802\/WJOG4607L): a multicentre, open-label, phase 3, randomised, controlled, non-inferiority trial","volume":"399","author":"Saji","year":"2022","journal-title":"Lancet"},{"key":"B243","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2212083","article-title":"Lobar or sublobar resection for peripheral stage IA non-small-cell lung cancer","volume":"388","author":"Altorki","year":"2023","journal-title":"N Engl J Med"},{"key":"B244","doi-asserted-by":"publisher","first-page":"e0540","DOI":"10.1101\/2023.09.15.23295451","article-title":"Spatial mapping of the hepatocellular carcinoma landscape identifies unique intratumoural perivascular-immune neighbourhoods","volume":"8","author":"Marsh-Wakefield","year":"2024","journal-title":"medRxiv"},{"key":"B245","doi-asserted-by":"publisher","DOI":"10.1038\/s41368-021-00146-0","article-title":"From bulk, single-cell to spatial RNA sequencing","volume":"13","author":"Li","year":"2021","journal-title":"Int J Oral Sci"},{"key":"B246","doi-asserted-by":"publisher","DOI":"10.1111\/his.13231","article-title":"The PD-1 expressing immune phenotype of T cell exhaustion is prominent in the \u2018immunoreactive\u2019 microenvironment of colorectal carcinoma","volume":"71","author":"Prall","year":"2017","journal-title":"Histopathology"},{"key":"B247","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.778329","article-title":"Colorectal cancer-associated immune exhaustion involves T and B lymphocytes and conventional NK cells and correlates with a shorter overall survival","volume":"12","author":"Sorrentino","year":"2021","journal-title":"Front Immunol"},{"key":"B248","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.750046","article-title":"Profiling tumor immune microenvironment of non-small cell lung cancer using multiplex immunofluorescence","volume":"12","author":"Peng","year":"2021","journal-title":"Front Immunol"},{"key":"B249","doi-asserted-by":"publisher","DOI":"10.1002\/1878-0261.12475","article-title":"The immune microenvironment in non\u2010small cell lung cancer is predictive of prognosis after surgery","volume":"13","author":"\u00d6jlert","year":"2019","journal-title":"Mol Oncol"},{"key":"B250","doi-asserted-by":"publisher","first-page":"16246","DOI":"10.1038\/s41598-024-64980-y","article-title":"The impact of tertiary lymphoid structures on tumor prognosis and the immune microenvironment in non-small cell lung cancer","volume":"14","author":"Weng","year":"2024","journal-title":"Sci Rep"},{"key":"B251","unstructured":"Fluorescent multiplex immunohistochemistry coupled with other state-of-the-art techniques to systematically characterize the tumor immune microenvironment\n          \n          \n          2026"},{"key":"B252","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.918900","article-title":"Next-generation pathology using multiplexed immunohistochemistry: Mapping tissue architecture at single-cell level","volume":"12","author":"Bosisio","year":"2022","journal-title":"Front Oncol"},{"key":"B253","doi-asserted-by":"publisher","DOI":"10.3390\/cells11040608","article-title":"Discordant genome assemblies drastically alter the interpretation of single-cell RNA sequencing data which can be mitigated by a novel integration method","volume":"11","author":"Potts","year":"2022","journal-title":"Cells"},{"key":"B254","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21197357","article-title":"Cellular and molecular mechanisms of CD8+ T cell differentiation, dysfunction and exhaustion","volume":"21","author":"Verdon","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B255","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1267918","article-title":"The nexus of dynamic T cell states and immune checkpoint blockade therapy in the periphery and tumor microenvironment","volume":"14","author":"Luo","year":"2023","journal-title":"Front Immunol"},{"key":"B256","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1038\/s42003-021-02142-w","article-title":"A combined approach for single-cell mRNA and intracellular protein expression analysis","volume":"4","author":"Reimeg\u00e5rd","year":"2021","journal-title":"Commun Biol"},{"key":"B257","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13184655","article-title":"Discordance of PD-L1 expression at the protein and RNA levels in early breast cancer","volume":"13","author":"Zerdes","year":"2021","journal-title":"Cancers"},{"key":"B258","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1548234","article-title":"Deciphering T-cell exhaustion in the tumor microenvironment: Paving the way for innovative solid tumor therapies","volume":"16","author":"Nair","year":"2025","journal-title":"Front Immunol"},{"key":"B259","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2024.109926","article-title":"Decoupling the correlation between cytotoxic and exhausted T lymphocyte states enhances melanoma immunotherapy response prediction","volume":"27","author":"Wang","year":"2024","journal-title":"iScience"},{"key":"B260","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1186\/s13046-023-02846-3","article-title":"CD28\/PD1 co-expression: Dual impact on CD8+ T cells in peripheral blood and tumor tissue, and its significance in NSCLC patients\u2019 survival and ICB response","volume":"42","author":"Palermo","year":"2023","journal-title":"J Exp Clin Cancer Res"},{"key":"B261","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2019.00317","article-title":"Single-cell RNA-seq technologies and related computational data analysis","volume":"10","author":"Chen","year":"2019","journal-title":"Front Genet"},{"key":"B262","doi-asserted-by":"publisher","DOI":"10.1038\/nmeth.4380","article-title":"Simultaneous epitope and transcriptome measurement in single cells","volume":"14","author":"Stoeckius","year":"2017","journal-title":"Nat Methods"},{"key":"B263","doi-asserted-by":"publisher","DOI":"10.3389\/fbinf.2025.1630161","article-title":"Quantitative measures to assess the quality of cellular indexing of transcriptomes and epitopes by sequencing data","volume":"5","author":"Sun","year":"2025","journal-title":"Front Bioinform"},{"key":"B264","doi-asserted-by":"publisher","DOI":"10.1016\/j.crmeth.2024.100938","article-title":"Multimodal hierarchical classification of CITE-seq data delineates immune cell states across lineages and tissues","volume":"5","author":"Caron","year":"2025","journal-title":"Cell Rep Methods"},{"key":"B265","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-024-01843-8","article-title":"Antitumor progenitor exhausted CD8+ T cells are sustained by TCR engagement","volume":"25","author":"Lan","year":"2024","journal-title":"Nat Immunol"},{"key":"B266","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1587658","article-title":"Safety and necessity of omitting mediastinal lymph node dissection in cN0\/N1 non-small cell lung cancer after neoadjuvant immunotherapy","volume":"16","author":"Zhou","year":"2025","journal-title":"Front Immunol"},{"key":"B267","doi-asserted-by":"publisher","DOI":"10.1038\/s43018-021-00292-8","article-title":"Temporal single-cell tracing reveals clonal revival and expansion of precursor exhausted T cells during anti-PD-1 therapy in lung cancer","volume":"3","author":"Liu","year":"2022","journal-title":"Nat Cancer"},{"key":"B268","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2022.01.003","article-title":"Unraveling B cell trajectories at single cell resolution","volume":"43","author":"Morgan","year":"2022","journal-title":"Trends Immunol"},{"key":"B269","doi-asserted-by":"publisher","first-page":"3120","DOI":"10.1038\/s41467-019-11049-4","article-title":"High-throughput targeted long-read single cell sequencing reveals the clonal and transcriptional landscape of lymphocytes","volume":"10","author":"Singh","year":"2019","journal-title":"Nat Commun"},{"key":"B270","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.705381","article-title":"Antibody repertoire analysis of tumor-infiltrating B cells reveals distinct signatures and distributions across tissues","volume":"12","author":"Aizik","year":"2021","journal-title":"Front Immunol"},{"key":"B271","doi-asserted-by":"publisher","first-page":"7834","DOI":"10.1038\/s41467-025-63200-z","article-title":"Lymph nodes molecular subtypes unravel lymph nodes heterogeneity and clinical implications in colorectal cancer","volume":"16","author":"Guan","year":"2025","journal-title":"Nat Commun"},{"key":"B272","doi-asserted-by":"publisher","first-page":"5321","DOI":"10.1038\/s41598-018-23629-3","article-title":"Morphology of immunomodulation in breast cancer tumor draining lymph nodes depends on stage and intrinsic subtype","volume":"8","author":"Seidl","year":"2018","journal-title":"Sci Rep"},{"key":"B273","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.966291","article-title":"Integrated single-cell transcriptome analysis of the tumor ecosystems underlying cervical cancer metastasis","volume":"13","author":"Li","year":"2022","journal-title":"Front Immunol"},{"key":"B274","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-023-02345-0","article-title":"Intratumoral dendritic cell\u2013CD4+ T helper cell niches enable CD8+ T cell differentiation following PD-1 blockade in hepatocellular carcinoma","volume":"29","author":"Magen","year":"2023","journal-title":"Nat Med"},{"key":"B275","doi-asserted-by":"publisher","first-page":"223","DOI":"10.12688\/f1000research.145171.3","article-title":"Tumor-driven stromal reprogramming in the pre-metastatic lymph node","volume":"13","author":"Piquet","year":"2025","journal-title":"F1000Res"},{"key":"B276","doi-asserted-by":"publisher","DOI":"10.1016\/j.xgen.2024.100723","article-title":"scTrends: A living review of commercial single-cell and spatial \u2018omic technologies","volume":"4","author":"Jonghe","year":"2024","journal-title":"Cell Genomics"},{"key":"B277","doi-asserted-by":"publisher","DOI":"10.1016\/j.scib.2026.01.034","article-title":"Mapping biology in space: From spatial transcriptomics platforms to analytical tools and databases","volume":"71","author":"Guo","year":"2026","journal-title":"Sci Bull"},{"key":"B278","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1568590","article-title":"Mapping immunotherapy potential: Spatial transcriptomics in the unraveling of tumor-immune microenvironments in head and neck squamous cell carcinoma","volume":"16","author":"Choi","year":"2025","journal-title":"Front Immunol"},{"key":"B279","doi-asserted-by":"publisher","first-page":"5029","DOI":"10.1038\/s41467-023-40271-4","article-title":"Spatial transcriptomics reveals distinct and conserved tumor core and edge architectures that predict survival and targeted therapy response","volume":"14","author":"Arora","year":"2023","journal-title":"Nat Commun"},{"key":"B280","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2025.101934","article-title":"Spatially resolved transcriptomics reveal the determinants of primary resistance to immunotherapy in NSCLC with mature tertiary lymphoid structures","volume":"6","author":"Peyraud","year":"2025","journal-title":"Cell Rep Med"},{"key":"B281","doi-asserted-by":"publisher","DOI":"10.1038\/s12276-022-00896-9","article-title":"Delineating the dynamic evolution from preneoplasia to invasive lung adenocarcinoma by integrating single-cell RNA sequencing and spatial transcriptomics","volume":"54","author":"Zhu","year":"2022","journal-title":"Exp Mol Med"},{"key":"B282","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.ccell.2025.01.012","article-title":"Integrative spatial analysis reveals tumor heterogeneity and immune colony niche related to clinical outcomes in small cell lung cancer","volume":"43","author":"Chen","year":"2025","journal-title":"Cancer Cell"},{"key":"B283","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1186\/s12967-024-05035-8","article-title":"Spatial insights into immunotherapy response in non-small cell lung cancer (NSCLC) by multiplexed tissue imaging","volume":"22","author":"Monkman","year":"2024","journal-title":"J Transl Med"},{"key":"B284","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1038\/s41421-023-00621-4","article-title":"Deciphering the role of immunoglobulin secreting Malignant lineages in the invasive frontiers of small cell lung cancer by scRNA-seq and spatial transcriptomics analysis","volume":"9","author":"Wu","year":"2023","journal-title":"Cell Discov"},{"key":"B285","doi-asserted-by":"publisher","first-page":"177","DOI":"10.14670\/HH-18-655","article-title":"Spatial transcriptomic analysis of tumour with high and low CAIX expression in TNBC tissue samples using GeoMxTM RNA assay","volume":"39","author":"Shamis","year":"2023","journal-title":"Histol Histopathol"},{"key":"B286","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13020287","article-title":"Overcoming challenges for CD3-bispecific antibody therapy in solid tumors","volume":"13","author":"Middelburg","year":"2021","journal-title":"Cancers (Basel)"},{"key":"B287","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2022-006234","article-title":"Spatial multi-omics revealed the impact of tumor ecosystem heterogeneity on immunotherapy efficacy in patients with advanced non-small cell lung cancer treated with bispecific antibody","volume":"11","author":"Song","year":"2023","journal-title":"J Immunother Cancer"},{"key":"B288","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s12935-025-04161-7","article-title":"Single-cell spatial analysis identifies ID1-high endothelial cells in tertiary lymphoid structures as predictors of durable response to immunotherapy in non-small cell lung cancer","volume":"26","author":"Matsumoto","year":"2026","journal-title":"Cancer Cell Int"},{"key":"B289","doi-asserted-by":"publisher","first-page":"116250","DOI":"10.1016\/j.celrep.2025.116250","article-title":"Integrated spatial transcriptomic profiling to dissect the cellular characteristics of tumor-associated tertiary lymphoid structures","volume":"44","author":"Li","year":"2025","journal-title":"Cell Rep"},{"key":"B290","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1016\/j.ccell.2025.03.011","article-title":"Spatial transcriptomics reveals tryptophan metabolism restricting maturation of intratumoral tertiary lymphoid structures","volume":"43","author":"Tang","year":"2025","journal-title":"Cancer Cell"},{"key":"B291","doi-asserted-by":"publisher","DOI":"10.1111\/imr.12405","article-title":"Tertiary lymphoid structures, drivers of the anti-tumor responses in human cancers","volume":"271","author":"Dieu-Nosjean","year":"2016","journal-title":"Immunol Rev"},{"key":"B292","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/j.immuni.2022.02.001","article-title":"Tertiary lymphoid structures generate and propagate anti-tumor antibody-producing plasma cells in renal cell cancer","volume":"55","author":"Meylan","year":"2022","journal-title":"Immunity"},{"key":"B293","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-17-1987","article-title":"Germinal centers determine the prognostic relevance of tertiary lymphoid structures and are impaired by corticosteroids in lung squamous cell carcinoma","volume":"78","author":"Sili\u0146a","year":"2018","journal-title":"Cancer Res"},{"key":"B294","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-1914-8","article-title":"Tertiary lymphoid structures improve immunotherapy and survival in melanoma","volume":"577","author":"Cabrita","year":"2020","journal-title":"Nature"},{"key":"B295","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2025.10.004","article-title":"Multimodal spatial-omics reveal co-evolution of alveolar progenitors and proinflammatory niches in progression of lung precursor lesions","volume":"44","author":"Peng","year":"2025","journal-title":"Cancer Cell"},{"key":"B296","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/s41573-018-0007-y","article-title":"Approaches to treat immune hot, altered and cold tumours with combination immunotherapies","volume":"18","author":"Galon","year":"2019","journal-title":"Nat Rev Drug Discov"},{"key":"B297","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1038\/s41392-024-01979-x","article-title":"Cold and hot tumors: From molecular mechanisms to targeted therapy","volume":"9","author":"Wu","year":"2024","journal-title":"Sig Transduct Target Ther"},{"key":"B298","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.ads6820","article-title":"Fibroblastic reticular cells form reactive myeloid cell niches in human lymph nodes","volume":"10","author":"L\u00fctge","year":"2025","journal-title":"Sci Immunol"},{"key":"B299","doi-asserted-by":"publisher","DOI":"10.1002\/eji.202451218","article-title":"Identification and mapping of human lymph node stromal cell subsets by combining single\u2010cell RNA sequencing with spatial transcriptomics","volume":"55","author":"Grasso","year":"2025","journal-title":"Eur J Immunol"},{"key":"B300","doi-asserted-by":"publisher","first-page":"3953","DOI":"10.1016\/j.cell.2024.05.055","article-title":"Open-ST: High-resolution spatial transcriptomics in 3D","volume":"187","author":"Schott","year":"2024","journal-title":"Cell"},{"key":"B301","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0249197","article-title":"Brief report: Lymph node morphology in stage II colorectal cancer","volume":"16","author":"Greenwood","year":"2021","journal-title":"PloS One"},{"key":"B302","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0012420","article-title":"Quantitative, architectural analysis of immune cell subsets in tumor-draining lymph nodes from breast cancer patients and healthy lymph nodes","volume":"5","author":"Setiadi","year":"2010","journal-title":"PloS One"},{"key":"B303","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-020-0635-3","article-title":"Lymph node stromal cells: cartographers of the immune system","volume":"21","author":"Krishnamurty","year":"2020","journal-title":"Nat Immunol"},{"key":"B304","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1016\/j.ccell.2024.11.005","article-title":"Chemotherapy induces myeloid-driven spatially confined T cell exhaustion in ovarian cancer","volume":"42","author":"Launonen","year":"2024","journal-title":"Cancer Cell"},{"key":"B305","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-022-03278-2","article-title":"Single-cell and spatial transcriptome analyzes revealed cell heterogeneity and immune environment alternations in metastatic axillary lymph nodes in breast cancer","volume":"72","author":"Mao","year":"2023","journal-title":"Cancer Immunol Immunother"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1803196\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T05:43:37Z","timestamp":1778823817000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1803196\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,15]]},"references-count":305,"alternative-id":["10.3389\/fonc.2026.1803196"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2026.1803196","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,15]]},"article-number":"1803196"}}